Research News
Research News
-
Landmark Supreme Court Decision Protects Free Access to PrEP, Preventive Healthcare
The Court’s ruling upholds a key provision of the Affordable Care Act and represents an important victory for HIV prevention and health equity
-
Researchers Target and Awaken Dormant HIV in Groundbreaking Advance
Researchers use lipid nanoparticles—LNP X—to insert mRNA capable of targeting and awakening dormant HIV, the main barrier to a cure.
-
Refining Anti-HIV Gene Therapies
Using gene therapy, researchers modify stem cells to defend against and attack HIV in a multi-pronged approach to achieve lifelong remission or an HIV cure.
-
Learning from Post-Treatment Control
A new study on post-treatment control of HIV, co-authored by amfAR grantee Michael Peluso, suggests a therapeutic approach targeting the earliest timepoints of HIV and immune system interaction.
-
What’s New in HIV Science?
amfAR’s Director of Research Dr. Andrea Gramatica leads a roundtable discussion about HIV research advances with Drs. Marina Caskey, Brad Jones, and Guinevere Lee.
-
Demystifying mRNA
Research using mRNA technology has led to lifesaving vaccines and may lead to treatments for HIV and other diseases—its potential deserves support.
-
Uncovering HIV’s Hiding Places
HIV cure researchers, including amfAR grantee Dr. Alexander O. Pasternak, scour blood and tissues seeking an elusive marker for HIV reservoir cells.
-
HIV Science: Dynamic, Inspiring
amfAR’s Dr. Andrea Gramatica highlights three research projects presented at CROI with the potential to reshape our understanding of HIV cure strategies.
-
Researchers Announce Two New Probable HIV Cure Cases
Researchers at CROI announce two new probable cases of HIV cure via stem cell transplantation with donor cells—the Chicago and Oslo Patients.
-
Inside an HIV Cure Trial
Researchers surveyed participants in an amfAR HIV cure trial about their experiences to learn how to fine-tune people-centered studies.
-
Curing HIV—How Far Have We Come?
It can be hard to keep track of the various cases of HIV having been cured or controlled in the absence of antiretroviral therapy. amfAR has put together a helpful summary.
-
Shaping the Future of HIV Research
amfAR VP and Director of Research Dr. Andrea Gramatica spoke with Dr. Melanie Ott, director of the Gladstone Institute of Virology, about her work on HIV, hepatitis C, and other viruses, and the promise of new and emerging technologies, and what she expects to see in the year ahead.
-
Can AI Help Piece Together the Puzzle of Cancer—and HIV?
New technology that more precisely analyzes patients’ biological data could deliver more effective, personalized treatment for people living with HIV.
-
Comprehending Post-Treatment Control of HIV
Researchers, including amfAR grantee Prof. John Frater, provide insight into the factors that influence how fast the virus rebounds after treatment interruption in HIV cure trials.
-
Peering Inside the Cell: A New Frontier in HIV Research
A new method of mapping cellular proteins before and after viral infection—a prime example of “spatial proteomics”—could revolutionize strategies to combat HIV.